Hemoadsorption for management of patients on veno-venous ECMO support for severe COVID-19 acute respiratory distress syndrome.
Travis C GeraciZachary N KonNader MoazamiStephanie H ChangJulius CarilloStacey ChenAnthony FargnoliMarjan AlimiHarvey PassAubrey GallowayDeane E SmithPublished in: Journal of cardiac surgery (2021)
Addition of hemoadsorption to VV-ECMO in patients with severe COVID-19 is feasible and reduces measured cytokine levels. However, in this small series, the precise impact on the overall clinical course and survival benefit still remains unknown.